Absolem Developing Products for Emerging Psychedelics Market

- December 12th, 2019

Absolem was recently featured in a sponsored article published by Equity Guru. 

Absolem was recently featured in a sponsored article published by Equity Guru.

The article discussed the potential for psychedelics like psilocybin to be integrated into mental health treatments and therapies. Early research has indicated there are a number of leading mental health ailments that could be treated with psilocybin, including PTSD, anxiety and depression. According to writer Chris Parry, psychedelics could also emerge to rival recreational drugs like alcohol and cannabis.

“Imagine the anxious and depressed being given just a little break from what’s weighing them down, without side effects…And imagine (and this is a real big one for me) having the effects of alcohol use, the social lubrication and stress relief, the adventure and the break from the every day – with no hangover.”

Absolem is currently developing three products under its One Up Pure Energy brand: Lions Mane, Cordyceps, and Reishi. Each product is designed to provide users a boost in different aspects of their life.

To learn more about Absolem read the feature in Equity Guru here.

Get the latest Biotech Investing stock information

Get the latest information about companies associated with Biotech Investing Delivered directly to your inbox.

Biotech Investing

Select None
Select All

Tags

Tags:

Leave a Reply